TREACE MEDICAL CONCEPTS, INC.
TMCI · XNASCIK 1630627fmd_1G156A6EDA577YTAR6YBTXDXRZManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2019 to Sep 30, 2026, 28 periods
| Line item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Total revenues | 39 | 57 | 94 | 142 | 187 | 209 | 213 |
| Cost of revenue | 8 | 12 | 17 | 26 | 35 | 41 | 43 |
| Gross profit | 32 | 45 | 78 | 116 | 152 | 168 | 170 |
| Research and development | 5 | 6 | 10 | 14 | 15 | 21 | 20 |
| Selling, general and administrative | 30 | 38 | 84 | 138 | 188 | 203 | 204 |
| Total operating expenses | 35 | 44 | 94 | 151 | 203 | 224 | 224 |
| Operating income | (4) | 1 | (17) | (35) | (51) | (56) | (54) |
| Interest expense | 1 | 3 | 4 | 4 | 5 | 5 | 5 |
| Other non-operating income (expense) | (1) | (5) | (4) | (8) | 2 | (0) | (5) |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | (4) | (4) | (21) | (43) | (50) | (56) | (59) |
| Net income to common shareholders | (5) | (4) | (21) | (43) | (50) | – | – |